FCGR3A and cancer: IgGs bound to antigens on the surface of cells (such as tumor antigens on cancer cells) crosslink FcγRIIIA (also known as CD16A) on natural killer (NK) cells and activate through their ITAM antibody-dependent cell-mediated cytotoxicity (ADCC, Figure 2D) [32].